✦ LIBER ✦

Phase I intrapatient dose escalation study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer

✍ Scribed by N Lo; S Ayers; E Catell; B Koetz; N Singh; G Alexander; F Lowe; D.W Rea

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Weekly epirubicin plus docetaxel as firs

✍ Gamucci, T; D'Ottavio, A M; Magnolfi, E; Barduagni, M; Vaccaro, A; Sperduti, I; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 111 KB

Dose-finding study of weekly docetaxel,

✍ S. H. Waters; A. Gillibrand; H. Berry; S. Kumar; G. Velikova; D. J. Dodwell; Tim 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 223 KB

Phase I study of docetaxel in combinatio

✍ Vasey, P A; Roché, H; Bisset, D; Terret, C; Vernillet, L; Riva, A; Ramazeilles, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Epirubicin and paclitaxel with G-CSF sup

✍ R. I. Lalisang; F. L. G. Erdkamp; C. J. Rodenburg; C. T. A. M. Knibbeler-van Ros 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 210 KB

Phase II Trial of Weekly Docetaxel/Gemci

✍ Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 482 KB

Multicentric phase II trial of gemcitabi

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB